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Recombinant human transferrin as well as N- and C-terminal half-transfertins, produced in
Escherichia coli,  are deposited in inclusion bodies by the bacteria. The isolation and purification
of the recombinant proteins from these inclusion bodies are described here. The amino acid
compositions and N-terminal sequences of the proteins were determined, and found to be in
agreement with the known protein structure of human serum transferrin. Renaturatlon of the
recombinant proteins is described, resulting in water-soluble iron-bindlng molecules. Iron binding
was conllrmed by 5%e  labelling, absorption spectrophotometry and EPR spectrometry. Copyright
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INTRODUCTION
Transferrin is an 80 kDa glycoprotein function-
ing as a ferric iron carrier in higher eukaryotes.
Being one of the major serum proteins, it has
been studied extensively since its first descrip-
tion (Schade  and Caroline, 1946).
The amino acid sequence of human transfer-
rin has been known for several years now
(MacGillivray  et al., 1982; Yang et al., 1984).
The protein can be divided into two globular
domains each containing one high affinity
binding site for iron. These two globular
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domains show a high degree of internal
homology.
The C-terminal domain (residues 337-679)
carries two branched N-linked glycans. These
two glycan chains are linked at the amide group
of the asparagine residues at positions 413 and
611 through a N-glycosidic linkage (Jamieson,
1964). No specific function has been ascribed to
the carbohydrate moieties of transferrin so far.
It has been reported that the glycan chains play
no role in the binding of transferrin to its
receptor (Mason et al., 1993)  neither do they
influence the secretion rate of transferrin by
hepatoma cells (Bauer et al., 1985). Carbo-
hydrate-deficient transferrin has been described
in several fish species of the Cyprinidae family
(Strati1 et al., 1983, 1985).
During certain physiological and pathological
conditions, such as pregnancy, rheumatoid
arthritis, malignancies and alcohol abuse (van
Eijk et al., 1987; de Jong et al., 1990, 1992; Ltger
et al., 1989; Yamashita et al., 1989; Stibler et al.,
1978), characteristic changes in the glycan
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structures occur. The significance of this
variation in microheterogeneity is not eluci-
dated totally. In vitro experiments employing
transferrins differing in their glycan compo-
sition have shown subtle differences in the
processing of these transferrins by the organs
most intimately involved in iron homeostasis
in man. These results have been fitted in a
model that explains the redistribution of iron
between iron stores in iron deficiency, preg-
nancy and states of chronic inflammation (de
Jong, 1993).
Studying the biochemical, structural and
physiological properties of human transferrin
lacking the carbohydrates could give more
insight into the function of the glycans. Initial
attempts to remove the glycans chemically or
enzymatically turned out to be unsuccessful.
Either transferrin was damaged irreversibly or
the carbohydrates were only partially removed
(de Jong et al., 1990, 1993). Another problem
with enzymatic deglycosylation is that it can be
applied only to small amounts of denatured
transferrin, although successful use of enzymes
under non-denaturing conditions has been
reported (Padda and Schrijvers, 1990). The
production of non-glycosylated transferrin in
eukaryotic cells using site-directed mutagenesis
has been described previously (Mason et al.,
1993).
Large quantities of aglycotransferrin can be
produced in a bacterial expression system (de
Smit et al., 1995). Bacteria lack the rough
endoplasmic reticulum and the Golgi system
and, therefore, are not able to attach N-linked
glycans to their products. For this reason, our
group has directed its efforts at developing a
system in which recombinant human transferrin
DNA could be expressed in E. coli and recently
has published the results (de Smit et al., 1995).
This bacterial expression system has been
employed as our source for aglycotransferrin.
Synthesized recombinant transferrin (rhTf)  is
deposited in a denatured state in large
amorphous particles called inclusion bodies.
This is true also for the N- and C-terminal
half-transferrins (rhTf/2C  and rhTf/2N,  respect-
ively). Therefore, studying biochemical proper-
ties of these proteins requires previous
renaturation.
Here, we report on the isolation, renaturation
and partial characterization of rhTf,  rhTf/2N
and rhTf/2C  from E. coli cultures expressing
these proteins. Following purification, we
determined the amino acid composition of the
recombinant proteins in order to compare this
with the theoretical composition that is known
from the primary structure. In addition, the first
lo-15 amino acids from the N-terminal side of
the three recombinant products were sequenced.
We renatured the recombinant transferrins
into water soluble proteins and determined their
iron-binding capacity.
MATERIALS AND METHODS
Production of rhTf, rhTf/2N and rhTfj2C  in
E. coli
Production of recombinant transferrin and
the recombinant half-molecules was performed
as described by de Smit et al. (1995).
PuriJication  of rhTf, rhTf/2N and rhrf/2C
To obtain cell lysates, the cultured bacteria
were harvested using a MSE Coolspin centri-
fuge at 2600 g for 15 min. The cells were
resuspended in 10 ml 50 mM Tris/HCl, 1 mM
EDTA, 250 mM NaCl, 5 mM DTT, pH 8.0 and
disrupted by adding approximately 100 000 U
lysozyme. After incubating for 30 min at room
temperature, the sample was snap-frozen by
submersing it in a mixture of solid CO, and
ethanol. The thawed sample was sonicated.
Approximately 300 U DNase I was added and
the sample was incubated for 45 min at room
temperature.
The inclusion bodies were isolated from the
cell lysate by centrifugation at 12 000 g for
15 min. The pellet was washed three times with
50 mM Tris/HCl, 1 mM DTT, pH 8.0 and
dissolved in 10 ml 8 M urea, 1 mM DTT,
40 mM Tris/HCl, 10% glycerol (v/v), pH 7.6.
Preparative SDS electrophoresis was used to
purify rhTf,  rhTf/2N  and rhTf/2C.  This was
performed with a model 392 Bio-Rad Prep Cell.
The rhTf,  rhTf/2N or rhTf/ZC  solution (600 ~1)
was mixed with an equal volume of 8% SDS
(w/v), 24% glycerol (v/v), 50 mM Tris/HCl, 4%
b-mercaptoethanol (v/v), 0.01% Serva blue G
(w/v), pH 6.8 and incubated for 30 min at 40°C.
This sample was applied to the polyacrylamide
gel (9% T, 3.3% C) of the Prep Cell. The
purities of hTf and its half-molecules were
examined on 9% SDS polyacrylamide gels after
being concentrated with Centriflo CF 25 cones
(Amicon). The samples were dialysed against
40 mM NaHCO,. The molecular cutoff was
approximately 10 kDa.
Recombinant human transferrin from E. coli 971
Amino acid analysis
The recombinant proteins were analysed
using an Alpha Plus 4151 amino acid analyser
(Pharmacia LKB Biochrom Ltd, Cambridge,
U.K.). The proteins were hydrolysed by mixing
50 ~1 (0.5-1.0 g/l) protein solution with 150 ~1
4 M paratoluene sulphonic acid and 2%
3-(2-amino  ethyl) indole HCl (van Eijk and van
Noort, 1986). This mixture was incubated for
24 hr at 110°C. After hydrolysis, the mixture
was titrated with 1 M NaOH to pH 2.0 and
0.2 M lithium citrate was added to a final
volume of 2 ml. This mixture (25 ~1)  was
analysed. During the analysis, the eluent was
mixed with a 0.2% (w/v) o&o-phthal  aldehyde
(OPA) ‘reagent in 1 M borate. The signal was
measured with a fluorometer F 1000 (Merck
Hitachi, Amsterdam, The Netherlands). As a
reference, we used a very pure human
transferrin preparation (4-sialo-bibi-antennary
transferrin of the genetic C, type) isolated from
serum obtained from adult healthy volunteers as
described by van Noort et al. (1994).
For protein sequencing, a model 473A
Protein Sequencer (Applied Biosystems) was
used, performing Edman degradation and
phenylthiohydantoin amino acid analysis.
Renaturation of rhTf,  rhTf/2C and rhTf/2N
Renaturation experiments were performed
with inclusion body solution without further
purification of the recombinant proteins. Prior
to renaturation, the protein concentration of the
inclusion body solution was determined accord-
ing to the method of Bradford (Bradford, 1976).
Renaturation was performed by diluting the
proteins in a renaturation buffer (0.1 mM
Na-EDTA, 0.1 mM Tris/HCl,  1.0 mM GSH,
pH 8.2, 6°C) to a concentration of 20 ,ug/ml.
The proteins were incubated for 15 min.
Subsequently, GSSG was added to a final
concentration of 0.5 mM.  This solution was
incubated for another 22 hr at 6°C. Renatura-
tion buffer was degassed thoroughly prior to use
and renaturation was performed under an
atmosphere of nitrogen. After incubation, the
solution was concentrated and dialysed against
10 mM NaHCO,  using an Ultrasette with an
omega 10 kDa membrane (Filtron). Sub-
sequently, the solution was filtered and concen-
trated further using an Amicon Stirred Cell with
a PM 10 membrane and finally Centriflo cones,
CF 25 (Amicon).
After concentration rhTf,  rhTf/2C  or rhTf/
2N was saturated with iron using a FeClJNTA
solution and separated from the other proteins
us ing  a Sepharose bound anti-transferrin
column (van Eijk and van Noort, 1976).
To demonstrate the iron-binding capacity of
the recombinant transferrins we saturated rhTf,
rhTf/2C  and rhTf/2N with iron using a
“FeCl,/NTA solution following standard pro-
cedures (59FeC13;  Amersham Life Science). The
iron-saturated samples were loaded onto two
12.5% homogeneous polyacrylamide PhastGels
(Pharmacia). One gel was used to illuminate an
X-ray film and the other gel was stained for
proteins using Coomassie brilliant blue R-250.
Also, we determined the molecular weight of the
proteins in the different samples by running
them on a 12.5% homogeneous SDS polyacryl-
amide gel.
Spectrophotometry and EPR
An absorption spectrum and an A28,,,47,,  ratio
of the iron-saturated recombinant transferrins
was determined using an Ultrospec III spectro-
photometer and application software (Pharma-
cia, LKB).
The EPR spectra were determined using a
Bruker EPR 200 D spectrometer as described by
Pierik and Hagen (1990).
RESULTS
The rhTf,  rhTf/2C  and rhTf/2N samples
purified from inclusion bodies by means of
preparative SDS electrophoresis each showed
one protein band on a 9% SDS-PAGE (Fig. 1).
As expected, rhTf migrated slightly faster then
hTf.  The lack of oligosaccharide chains reduces
the Mw by approximately 4 kDa. The rhTf/2N
and rhTf/2C  showed bands just above the
32.5 kDa marker, which corresponds to the
calculated Mw of respectively 37.3 and
38.3 kDa.
In Table 1, the amino acid composition of
rhTf,  rhTf/2N and rhTf/2C  is compared with
hTf.  The composition of the recombinant
transferrins corresponds very well to the
references. Most amino acids show less then 5%
deviation from the expected values. In Table 2,
the first 10-15 amino acids sequenced from the
N-terminal side of the recombinant proteins are
compared with the expected amino acids (Yang
et al., 1984). These sequences match the
references exactly, except for one N-terminal
extra methionine at each recombinant protein
and a glutamic acid replacement by glutamine in
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rhTf/2C.  The latter was introduced during
construction of the expression plasmid and will
be explained in the discussion.
An absorption spectrum of the iron-saturated
recombinant transferrins was determined rang-
ing from 280 to 600 nm. Normal diferric human
transferrin has an absorption maximum at
465 nm. The recombinant transferrins showed
spectra similar to those of diferric human
transferrin with an absorption maximum at 462,
459 and 464 nm for rhTf,  rhTf/2C  and rhTf/2N,
respectively. Normal diferric transferrin has an
A280j465 ratio equivalent to 21; this value also has
been reported for iron-saturated hTf/2N (Funk
et al., 1990). For rhTf,  rhTf/2C  and rhTf/2N,
we calculated values of 30, 28 and 24. Assuming
these ratios can be converted into iron-satu-
ration values, as can be done with normal
transferrin, these figures correspond with 70 and
90% iron-saturation for rhTf and rhTf/2N,
respectively. Assuming the A280,465  ratio for
iron-saturated hTfj2C is equal to that for hTf
and hTf/2N,  the calculated value for rhTf/2C
corresponds with 75% iron-saturation.
The EPR spectra of the recombinant transfer-
rins are nearly identical with the spectrum of
native transferrin (Fig. 4).
The renatured recombinant transferrins were
1 2 3
saturated with 59Fe using a 59FeC1,/NTA
solution. This sample was run on a native
polyacrylamide gel. The 59Fe saturated recombi-
nant proteins all show more than one band on
the autoradiograph [Fig. 2(B)]. The difference in
migration pattern between rhTf/2C  and rhTf/
2N on the autoradiograph and the native
polyacrylamide gel is remarkable. This differ-
ence is not seen on the SDS polyacrylamide gel
(Fig. 3).
DISCUSSION
Here, we report on the purification and
renaturation of human transferrin, C-terminal
half-transferrin and N-terminal half-transferrin,
produced in E. coli  as described by de Smit et al.
(1995). After purification, the amino acid
compositions of the recombinant transferrin
and the recombinant N- and C-terminal
half-transferrins were determined. These com-
positions match very well with the ones to be
expected, not only proving that the samples
contain the proteins of interest to us, but also
that they are very pure.
The N-terminal sequencing shows that the
recombinant transferrins all have an extra
methionine at the N-terminus (Table 2). The
Fig. 1. The SDS-PAGE (9%) showing the purified recombinant proteins and the solubilized  inclusion
bodies from which these proteins were isolated. Lane 1: hTf;  lane 2: rhTf;  lane 3: inclusion body solution
containing rhTf;  lane 4: rhTf/ZN;  lane 5: inclusion body solution containing rhTf/2N;  lane 6: rhTf/2C;
lane 7: inclusion body solution containing rhTf/2C.  Markers are indicated in kDa.  Staining was done with
Coomassie brilliant blue G250.
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Table 1 . Amino acid analysis of recombinant transferrins (mol amino acid/m01  protein)*
Reference Reference
Recombinant Reference values values
human values N-Terminal N-terminal C-Terminal C-terminal
transferrin serum half-transferrin part of serum half-transferrin part of serum
(rhTf  ) transferrin (rhTf/ZN) transferrin (rhTf/2C) transferrin
Lysine 53.7 5 8 25.9 2 7
Histidine 18.0 1 9 9.2 9
Arginine 24.9 2 6 10.6 12
Aspartate + NH?* 74.0 7 9 35.3 3 6
Threonine 30.2 3 0 12.9 13
Serine 40.4 4 1 20.2 21
Glutamate + NH,* 57.8 5 9 28.5 2 9
Proline N.D.t 3 2 N.D. 20
Glycine 51.5 5 0 25.2 24
Alanine 58.4 5 7 31.7 3 2
Cysteine N.D. 3 8 N.D. 1 6
Valine 44.7 45 22.7 22
Methionine 9.4 9 5.8 5
Isoleucine 14.6 15 7.8 8
Leucine 55.2 5 9 30.7 2 9
Tyrosine 26.0 2 6 15.2 14
Phenylalanine 25.8 2 8 15.4 16
Tryptophan 7.5 8 2.9 3
Total
Total minus Cys
and minus Pro
Deviation from
predicted values:
592.1
679
609 300
336
300
3.6% 3.3% 5.5%
26.9
8.7
14.7
42.2
16.3
20.6
32.4
N.D.
27.3
25.3
N.D.
22.3
5.3
7.6
29.5
12.0
13.1
4.2
308.4
31
10
14
4 3
17
2 0
3 0
12
2 6
2 5
2 2
2 3
4
7
3 0
12
12
5
3 4 3
309
*Sums of asparagine and aspartate and sums of glutamine and glutamate are given because of interconversion of these
amino acids in the hydrolysis procedure.
tThe  colour  reactant used in the analysis procedure yields low absorbance products for proline  and cysteine, which therefore
are not determined (N.D.).
$The  deviation represents the cumulated difference between determined numbers of separate amino acids in the transferrin
* species compared to the reference values derived from figures based on the transferrin characterization by Yang et al.
(1984).
difference in the amino acid sequence of For our first renaturation experiments, we
rhTf/2C  (amino acid 338) is due to the used SDS/urea-denatured reduced hTf. All
introduction of a KpnI-site  in the transferrin attempts to renature transferrin after such
cDNA (de Smit et al., 1995). Apart from this, treatment failed. Although total removal of
the amino acid sequences of the recombinant SDS from proteins has been reported (Kapp
transferrins match the expected sequences and Vinogradov, 1978; Hager and Burgess,
exactly (Yang et al., 1984). 1980; Suzuki and Terada, 1988)  we were not
Table 2. Amino acid sequence of the recombinant transferrins, sequenced from the N-terminus, compared with the expected
sequence according to Yang et al. (1984)
Serum Tf rhTf rhTf/SN Serum Tf rhTf/2C
01 Val
0 2 Pro
0 3 Asp
04 Lys
0 5 Thr
06 Val
0 7 Arg
0 8 Trp
0 9 cys
10 Ala
1 1 Vat
12 Ser
13 Glu
14 His
Met Met
Vat Val
Pro Pro
Asp Asp
LYS LYS
Thr Thr
Val Val
Arg As
Trp ‘b
CYS CYS
Ala Ala
Val Val
Ser Ser
Glu Glu
His His
337 Asp
338 Glu
339 cys
340 L y s
3 4 1 Pro
342 Val
3 4 3 L y s
344 Trp
345 cys
346 Ala
347 Leu
Met
ASQ
Gln
CYS
LYS
Pro
Val
LYS
Trp
CYS
Ala
Leu
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Fig. 2. (Left panel) Native PAGE (12.5%) showing the renatured recombinant proteins. Lane 1: hTf
(Behringwerke); lane 2: rhTf;  lane 3: rhTf/2C;  lane 4: rhTf/2N.  (Right panel) Autoradiograph of a
comparable gel to that shown in the left panel, except the recombinant proteins were saturated with S9Fe.
able to remove this detergent from denatured
transferrin without complete precipitation of
the protein of interest. Hence, renaturation
experiments were performed with inclusion
body solution following a procedure derived
from Hirose (Hirose et al., 1989; Hirose and
Yamashita, 1991) and adapted to our exper-
imental system; i.e. prior isolation of the
recombinant proteins by means of preparative
SDS electrophoresis was abandoned.
After renaturation and purification, the
recombinant transferrins all show a few bands
on a native polyacrylamide gel [Fig. 2(A)]. This
phenomenon is not caused by differences in
molecular weight, because the same samples all
show one single band on an SDS gel (Fig. 3)
1 2 3 4
Fig. 3. The SDS-PAGE (12.5%) showing the renatured recombinant proteins. Lane 1: hTf
(Behringwerke); lane 2: rhTf;  lane 3: rhTf/2C;  lane 4: rhTf/2N.  Markers are indicated in kDa.  Staining
was done with Coomassie brilliant blue R250.
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Fig. 4. Comparison of the EPR spectra of hTf  and the recombinant transferrins. A: hTf;  B: rhTf;  C:
rhTf/ZN;  D: rhTf/2C.  EPR conditions for (A): microwave frequency, 9315 MHz; microwave power,
80 mW; modulation amplitude, 0.8 mT;  temperature, 9 K. EPR conditions for (B): microwave frequency,
9315 MHz; microwave power, 0.8 mW; modulation amplitude, 0.5 mT;  temperature, 9 K.
except for a weak second band in lane 2,
corresponding with half-transferrin. This could
be explained easily as a result of proteolytic
activity in E. coli during growth or during the
inclusion body isolation procedure.
An explanation for the several minor bands
on the native gel could be that different
mobilities represent different conformations of
the protein, e.g. due to variations in disulphide
bond formation. These conformational differ-
ences could affect the iron-binding sites,
resulting in a decreased iron saturation. One of
the major rhTf/2C  bands migrated approxi-
mately as far as the rhTf bands on the native
12.5% homogeneous polyacylamide gel
[Fig. 2(A)] but, on a gradient polyacrylamide gel
(PhastGel S-25%),  this band shifted more
towards the rhTf/2N bands, indicating that this
band is not a dimer. Dimerization as a result of
intermolecular disulphide bridge formation was
excluded for all the recombinant transferrins,
since none of the recombinant proteins showed
any extra bands on a 12.5% homogeneous
polyacrylamide SDS gel run under non-reduc-
ing conditions compared with an SDS gel run
under reducing conditions (not shown). In both
cases, the recombinant proteins were saturated
with SDS by incubating them in sample buffer
(with or without /I-mercaptoethanol) at 40°C
for 30 min.
The recombinant transferrins all are capable
of binding iron as shown on the autoradiograph
[Fig. 2(B)]. This is indicated also by the
similarity of the recombinant transferrin ad-
sorption spectra with the spectrum of iron-satu-
rated hTf.  All the spectra have an adsorption
maximum near 465 nm. The EPR spectra of the
recombinant proteins are nearly identical with
the EPR spectrum of hTf. Thus, the iron atoms
in the recombinant proteins and in the native
transferrin are bound in a similar way. This
strongly suggests that the iron-binding sites of
the recombinant transferrins are intact.
The minor differences seen in the EPR spectra
are possibly a result of differences between the
transferrins, e.g. lack of oligosaccharides.
As described by de Smit et al. (1995)
production of recombinant transferrin in E. coli
amounts to 60 mg/l.  The renaturation pro-
cedure has a final yield of approximately 5%.
Several authors have reported the production
of recombinant transferrin in E. coli (Hersh-
berger et al., 1991; Steinlein and Ikeda, 1993).
Hershberger et al. (1991) also reported on
renaturation of recombinant transferrin,
although no data were shown. Our work
describes the production as well as the isolation,
partial characterization, renaturation and iron-
binding capacity of recombinant transferrin and
both its half molecules. Renaturation of the
recombinant transferrins results in water-
soluble, iron-binding molecules.
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